Failing towards a successful global company - Resyn biosciences

What is possible from a failed experiment? A biotech company, Resyn biosciences! In the 5th episode of the Africa biotech conversations podcast, I spoke with Stoyan Stoychev about proteomics and the Resyn biosciences story. The polymer technology behind the products was a result of a failed biocatalysis experiment. The curiosity to explore what could be done with the novel polymer and support from the CSIR with funding, work space, researchers etc. led to a spin out of the company from the CSIR. We discussed among others: strategic creation of a successful proteomic portfolio of products from the technology the mindset and strategy for success in local and global markets current trends of proteomics in Africa building brand reputation through networking and peer-reviewed publications networking tips for scientists strategy for the organic growth of the company when they failed to secure funding from angel investors keeping up with the rapid development of the omics space and demand for more robust, high-throughput, sensitive, and user-friendly solutions by establishing R&D partnerships with the research community. Stoyan has over 13 years of hands-on experience in mass spectrometry, proteomics and protein characterization. When he is not working on proteomics in his numerous roles, he loves adrenaline hobbies like motorcycling.